Connection

Jacques Izopet to Humans

Back to Details
This is a "connection" page, showing publications Jacques Izopet has written about Humans.
Jacques Izopet
Connection Strength
0.335
Humans
  1. Protection of Healthcare Workers Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection. Clin Infect Dis. 2021 10 05; 73(7):1323-1324.
    View in: PubMed
    Score: 0.008
  2. Testing individual and pooled saliva samples for sars-cov-2 nucleic acid: a prospective study. Diagn Microbiol Infect Dis. 2021 Nov; 101(3):115478.
    View in: PubMed
    Score: 0.008
  3. One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection. J Infect. 2021 09; 83(3):381-412.
    View in: PubMed
    Score: 0.008
  4. The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics. Sci Rep. 2021 06 15; 11(1):12597.
    View in: PubMed
    Score: 0.008
  5. Influence of age on the spread of SARS-CoV-2 variant B.1.1.7. J Clin Virol. 2021 08; 141:104872.
    View in: PubMed
    Score: 0.008
  6. Influence of SARS-CoV-2 Variant B.1.1.7, Vaccination, and Public Health Measures on the Spread of SARS-CoV-2. Viruses. 2021 05 12; 13(5).
    View in: PubMed
    Score: 0.008
  7. Diagnosis options in patients suffering from COVID-19-like symptoms. J Med Virol. 2021 Jul; 93(7):4076-4077.
    View in: PubMed
    Score: 0.008
  8. COVID-19 pandemic period, where are the seasonal viruses? J Med Virol. 2021 Jul; 93(7):4097-4098.
    View in: PubMed
    Score: 0.008
  9. Estimating the impact of public health strategies on the spread of SARS-CoV-2: Epidemiological modelling for Toulouse, France. Rev Med Virol. 2021 09; 31(5):1-8.
    View in: PubMed
    Score: 0.007
  10. Side effect of a 6 p.m curfew for preventing the spread of SARS-CoV-2: A modeling study from Toulouse, France. J Infect. 2021 May; 82(5):186-230.
    View in: PubMed
    Score: 0.007
  11. Quantifying the impact of public health protection measures on the spread of SARS-CoV-2. J Infect. 2021 03; 82(3):414-451.
    View in: PubMed
    Score: 0.007
  12. Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France. J Infect. 2021 01; 82(1):e29-e32.
    View in: PubMed
    Score: 0.007
  13. Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers. J Clin Virol. 2020 09; 130:104580.
    View in: PubMed
    Score: 0.007
  14. Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens. J Clin Virol. 2020 08; 129:104541.
    View in: PubMed
    Score: 0.007
  15. Clinical performance of a rapid test compared to a microplate test to detect total anti SARS-CoV-2 antibodies directed to the spike protein. J Clin Virol. 2020 09; 130:104528.
    View in: PubMed
    Score: 0.007
  16. Children are protected against SARS-CoV-2 infection. J Clin Virol. 2020 07; 128:104451.
    View in: PubMed
    Score: 0.007
  17. The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France. J Infect. 2020 Aug; 81(2):318-356.
    View in: PubMed
    Score: 0.007
  18. COVID-19, Virology and Geroscience: A Perspective. J Nutr Health Aging. 2020; 24(7):685-691.
    View in: PubMed
    Score: 0.007
  19. Hepatitis E Virus Infections among Patients with Acute Febrile Jaundice in Burkina Faso. Viruses. 2019 06 14; 11(6).
    View in: PubMed
    Score: 0.007
  20. Performance of a commercial assay for detecting and quantifying HEV RNA in faeces. J Clin Virol. 2018 12; 109:1-5.
    View in: PubMed
    Score: 0.006
  21. Detection of Zika, dengue and chikungunya viruses using single-reaction multiplex real-time RT-PCR. Diagn Microbiol Infect Dis. 2018 Dec; 92(4):284-287.
    View in: PubMed
    Score: 0.006
  22. Diversity of hepatitis E virus genotype 3. Rev Med Virol. 2018 09; 28(5):e1987.
    View in: PubMed
    Score: 0.006
  23. A fully automated system using transcription-mediated amplification for the molecular diagnosis of hepatitis E virus in human blood and faeces. J Clin Virol. 2018 08; 105:109-111.
    View in: PubMed
    Score: 0.006
  24. Performance comparison of deep sequencing platforms for detecting HIV-1 variants in the pol gene. J Med Virol. 2018 09; 90(9):1486-1492.
    View in: PubMed
    Score: 0.006
  25. Should Persistent Hepatitis E Virus Replication in Transplant Patients Be Tolerated? Transplantation. 2018 02; 102(2):e84-e85.
    View in: PubMed
    Score: 0.006
  26. [HEV and transfusion-recipient risk]. Ann Pharm Fr. 2018 Mar; 76(2):89-96.
    View in: PubMed
    Score: 0.006
  27. HEV and transfusion-recipient risk. Transfus Clin Biol. 2017 Sep; 24(3):176-181.
    View in: PubMed
    Score: 0.006
  28. Rabbit Hepatitis E Virus Infections in Humans, France. Emerg Infect Dis. 2017 07; 23(7):1191-1193.
    View in: PubMed
    Score: 0.006
  29. Zika Virus Infection and Prolonged Viremia in Whole-Blood Specimens. Emerg Infect Dis. 2017 05; 23(5):863-865.
    View in: PubMed
    Score: 0.006
  30. Characterization of the lipid envelope of exosome encapsulated HEV particles protected from the immune response. Biochimie. 2017 Oct; 141:70-79.
    View in: PubMed
    Score: 0.006
  31. Evaluation of two VIDAS ®prototypes for detecting anti-HEV IgG. J Clin Virol. 2017 04; 89:46-50.
    View in: PubMed
    Score: 0.006
  32. Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor use. Sci Rep. 2017 02 10; 7:42215.
    View in: PubMed
    Score: 0.006
  33. Hepatitis E Virus Infection in Solid Organ Transplant Recipients, France. Emerg Infect Dis. 2017 02; 23(2):353-356.
    View in: PubMed
    Score: 0.006
  34. Comparison of Cobas® HPV and Anyplex™ II HPV28 assays for detecting and genotyping human papillomavirus. Diagn Microbiol Infect Dis. 2017 Jan; 87(1):25-27.
    View in: PubMed
    Score: 0.005
  35. Performance of a completely automated system for monitoring CMV DNA in plasma. J Clin Virol. 2016 06; 79:25-31.
    View in: PubMed
    Score: 0.005
  36. The use of a multiplex real-time PCR assay for diagnosing acute respiratory viral infections in children attending an emergency unit. J Clin Virol. 2014 Nov; 61(3):411-7.
    View in: PubMed
    Score: 0.005
  37. Ribavirin for chronic hepatitis E virus infection. N Engl J Med. 2014 06 19; 370(25):2447-8.
    View in: PubMed
    Score: 0.005
  38. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis. 2010 Mar 01; 50(5):e30-3.
    View in: PubMed
    Score: 0.003
  39. Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage. J Clin Virol. 2010 Feb; 47(2):126-30.
    View in: PubMed
    Score: 0.003
  40. HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response. Antivir Ther. 2008; 13(4):537-45.
    View in: PubMed
    Score: 0.003
  41. Use of two real-time polymerase chain reactions (PCRs) to detect herpes simplex type 1 and 2-DNA after automated extraction of nucleic acid. J Med Virol. 2004 Nov; 74(3):459-62.
    View in: PubMed
    Score: 0.002
  42. Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant Patients. Transplantation. 2021 10 01; 105(10):e146-e147.
    View in: PubMed
    Score: 0.002
  43. Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients. Am J Transplant. 2022 01; 22(1):322-323.
    View in: PubMed
    Score: 0.002
  44. High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients. Nephrol Dial Transplant. 2021 08 27; 36(9):1704-1709.
    View in: PubMed
    Score: 0.002
  45. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients. N Engl J Med. 2021 08 12; 385(7):661-662.
    View in: PubMed
    Score: 0.002
  46. Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation. Kidney Int. 2021 10; 100(4):915-927.
    View in: PubMed
    Score: 0.002
  47. Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants. Ann Intern Med. 2021 09; 174(9):1336-1338.
    View in: PubMed
    Score: 0.002
  48. Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics. Clin Infect Dis. 2020 12 31; 71(11):2962-2964.
    View in: PubMed
    Score: 0.002
  49. Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon ? and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 Infection. J Infect Dis. 2019 07 31; 220(5):830-840.
    View in: PubMed
    Score: 0.002
  50. Hepatitis E Virus (HEV) Open Reading Frame 2 Antigen Kinetics in Human-Liver Chimeric Mice and Its Impact on HEV Diagnosis. J Infect Dis. 2019 07 31; 220(5):811-819.
    View in: PubMed
    Score: 0.002
  51. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin. Viruses. 2019 07 09; 11(7).
    View in: PubMed
    Score: 0.002
  52. Transfusion-Transmitted Hepatitis E Virus Infection in France. Transfus Med Rev. 2019 07; 33(3):146-153.
    View in: PubMed
    Score: 0.002
  53. Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France. J Antimicrob Chemother. 2019 05 01; 74(5):1417-1424.
    View in: PubMed
    Score: 0.002
  54. Should 12- or 24-week post-ribavirin follow-up be considered to define sustained virological response in transplant patients treated for chronic hepatitis E virus infection? Transpl Infect Dis. 2019 06; 21(3):e13065.
    View in: PubMed
    Score: 0.002
  55. Failure to respond to ribavirin despite elevated intra-erythrocyte zinc level in transplant-patients with chronic hepatitis E virus infection. Transpl Infect Dis. 2019 04; 21(2):e13050.
    View in: PubMed
    Score: 0.002
  56. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. Clin Infect Dis. 2018 11 28; 67(12):1883-1889.
    View in: PubMed
    Score: 0.002
  57. Genotype specific pathogenicity of hepatitis E virus at the human maternal-fetal interface. Nat Commun. 2018 11 12; 9(1):4748.
    View in: PubMed
    Score: 0.002
  58. Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients. J Hepatol. 2019 01; 70(1):206-209.
    View in: PubMed
    Score: 0.002
  59. Accurate quantification of CXCR4-using HIV-1 variants by Illumina deep-sequencing. AIDS. 2018 10 23; 32(16):2429-2431.
    View in: PubMed
    Score: 0.002
  60. Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management. Kidney Int. 2018 10; 94(4):663-673.
    View in: PubMed
    Score: 0.002
  61. Transmission of Hepatitis E Virus With Plasma Exchange in Kidney Transplant Recipients: A Retrospective Cohort Study. Transplantation. 2018 08; 102(8):1351-1357.
    View in: PubMed
    Score: 0.002
  62. Acute hepatitis E in French patients and neurological manifestations. J Infect. 2018 09; 77(3):220-226.
    View in: PubMed
    Score: 0.002
  63. Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipients. Liver Int. 2018 12; 38(12):2178-2189.
    View in: PubMed
    Score: 0.002
  64. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation. Transpl Infect Dis. 2018 Aug; 20(4):e12917.
    View in: PubMed
    Score: 0.002
  65. Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen. Clin Infect Dis. 2018 05 02; 66(10):1588-1594.
    View in: PubMed
    Score: 0.002
  66. Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial. J Antimicrob Chemother. 2018 03 01; 73(3):738-747.
    View in: PubMed
    Score: 0.002
  67. [Hepatitis E virus infection]. Rev Prat. 2018 Mar; 68(3):286-290.
    View in: PubMed
    Score: 0.002
  68. Monitoring human enteric viruses in wastewater and relevance to infections encountered in the clinical setting: a one-year experiment in central France, 2014 to 2015. Euro Surveill. 2018 02; 23(7).
    View in: PubMed
    Score: 0.002
  69. Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohort. Antivir Ther. 2018; 23(4):307-314.
    View in: PubMed
    Score: 0.001
  70. A European multicenter study on the analytical performance of the VERIS HBV assay. J Clin Virol. 2018 Feb - Mar; 99-100:50-56.
    View in: PubMed
    Score: 0.001
  71. Hepatitis E virus infection. Nat Rev Dis Primers. 2017 Nov 16; 3:17086.
    View in: PubMed
    Score: 0.001
  72. Transfusion-acquired hepatitis E infection misdiagnosed as severe critical illness polyneuromyopathy in a heart transplant patient. Transpl Infect Dis. 2017 Dec; 19(6).
    View in: PubMed
    Score: 0.001
  73. Retreatment with direct-acting antivirals of genotypes 1-3-4 hepatitis C patients who failed an anti-NS5A regimen in real world. J Hepatol. 2018 03; 68(3):595-597.
    View in: PubMed
    Score: 0.001
  74. Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein. Gastroenterology. 2018 01; 154(1):211-223.e8.
    View in: PubMed
    Score: 0.001
  75. Kinetics of anti-ZIKV antibodies after Zika infection using two commercial enzyme-linked immunoassays. Diagn Microbiol Infect Dis. 2018 Jan; 90(1):26-30.
    View in: PubMed
    Score: 0.001
  76. A European multicientre study on the comparison of HBV viral loads between VERIS HBV assay and Roche COBAS® TAQMAN® HBV test, Abbott RealTime HBV assay, Siemens VERSANT HBV assay, and Qiagen artus HBV RG kit. J Clin Virol. 2017 10; 95:76-83.
    View in: PubMed
    Score: 0.001
  77. Chronic hepatitis E virus infection in a cirrhotic patient: A case report. Medicine (Baltimore). 2017 Sep; 96(39):e7915.
    View in: PubMed
    Score: 0.001
  78. Clinical phenotype and outcome of hepatitis E virus-associated neuralgic amyotrophy. Neurology. 2017 Aug 29; 89(9):909-917.
    View in: PubMed
    Score: 0.001
  79. Hepatitis E virus infection and acute non-traumatic neurological injury: A prospective multicentre study. J Hepatol. 2017 11; 67(5):925-932.
    View in: PubMed
    Score: 0.001
  80. Malignancies in hepatitis C virus-positive and -negative kidney transplant recipients: A case-controlled study. Transpl Infect Dis. 2017 Aug; 19(4).
    View in: PubMed
    Score: 0.001
  81. Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study. J Antimicrob Chemother. 2017 06 01; 72(6):1769-1773.
    View in: PubMed
    Score: 0.001
  82. A European multicientre study on the comparison of HIV-1 viral loads between VERIS HIV-1 Assay and Roche COBAS® TAQMAN® HIV-1 test, Abbott RealTime HIV-1 Assay, and Siemens VERSANT HIV-1 Assay. J Clin Virol. 2017 07; 92:75-82.
    View in: PubMed
    Score: 0.001
  83. European Multicenter Study on Analytical Performance of Veris HIV-1 Assay. J Clin Microbiol. 2017 07; 55(7):2055-2063.
    View in: PubMed
    Score: 0.001
  84. Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma. PLoS One. 2017; 12(4):e0174651.
    View in: PubMed
    Score: 0.001
  85. A European multicentre study on the comparison of HCV viral loads between VERIS HCV assay and COBAS® TaqMan® HCV Test and RealTime HCV Assay. J Clin Virol. 2017 05; 90:18-25.
    View in: PubMed
    Score: 0.001
  86. Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma. Antiviral Res. 2017 05; 141:150-154.
    View in: PubMed
    Score: 0.001
  87. European Multicenter Study on Analytical Performance of DxN Veris System HCV Assay. J Clin Microbiol. 2017 04; 55(4):1186-1192.
    View in: PubMed
    Score: 0.001
  88. CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals. Mucosal Immunol. 2016 09; 9(5):1137-50.
    View in: PubMed
    Score: 0.001
  89. Hepatitis C virus and kidney disease. Clin Res Hepatol Gastroenterol. 2013 Sep; 37(4):328-33.
    View in: PubMed
    Score: 0.001
  90. Antiviral effect of maraviroc in semen: a case report. Antivir Ther. 2012; 17(5):933-6.
    View in: PubMed
    Score: 0.001
  91. Treatment of hepatitis C virus infection after kidney transplantation. Contrib Nephrol. 2012; 176:87-96.
    View in: PubMed
    Score: 0.001
  92. [Cytomegalovirus effects in solid organ transplantation and the role of antiviral prophylaxis]. Nephrol Ther. 2010 Nov; 6(6):505-12.
    View in: PubMed
    Score: 0.001
  93. Low frequency of CXCR4-using viruses in patients at the time of primary non-subtype-B HIV-1 infection. J Clin Microbiol. 2010 Oct; 48(10):3487-91.
    View in: PubMed
    Score: 0.001
  94. Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection. Gastroenterology. 2002 Nov; 123(5):1494-9.
    View in: PubMed
    Score: 0.001
  95. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation. 1995 May 27; 59(10):1426-31.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.